FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

ICU Medical Recalls Potassium Chloride Lot

ICU Medical recalls one lot of potassium chloride injection bags packaged in cases indicating 20 mEq per bag due to a mislabeling incident.

latest-news-card-1
Human Drugs

New Endpoint Option for Alcohol Use Disorder

CDER posts a drug development qualifying tool to support treatments for alcohol use disorder products.

Biologics

Clinical Hold on Moderna Norovirus Vaccine

FDA places a clinical hold on a Phase 3 study evaluating Modernas trivalent vaccine against norovirus (mRNA-1403) after a case of Guillain-Barr syndro...

latest-news-card-1
Biologics

FDA OKs Sanofis Merilog, a Novolog Biosimilar

FDA approves Sanofi-Aventis Merilog (insulin-aspart-szjj) as a biosimilar to Novo Nordisks Novolog (insulin aspart) for improving glycemic control in ...

latest-news-card-1
Medical Devices

Abiomed Recalls Impella Heart Pumps

Abiomed recalls its Impella RP with SmartAssist and Impella RP Flex with SmartAssist heart pumps to update their use instructions due to a risk that t...

latest-news-card-1
Human Drugs

FDA Still Faster than EMA on Cancer Approvals

A Friends of Cancer Research study update says FDA continues to review and approve novel cancer drugs faster than the European Medicines Agency.

latest-news-card-1
Biologics

Sanofi/J&J Scrap E. Coli Vaccine Candidate

Sanofi and Johnson & Johnson stop the development of their vaccine candidate for extraintestinal pathogenic E. coli because Phase 3 data show that it ...

latest-news-card-1
Human Drugs

Court Rules for FDA in Vanda Label Case

The DC District Court rules for FDA in a Vanda Pharmaceuticals lawsuit seeking an agency order to revoke the approval of a Teva ANDA for a generic cop...

Human Drugs

More Accelerated Approval Changes Needed: Kaiser

The Kaiser Permanente healthcare system calls for FDA and congressional changes to improve the utility of the drug accelerated approval pathway.

latest-news-card-1
Human Drugs

Astellas Wins Revised Label for Izervay

FDA approves an Astellas Pharma supplemental NDA for Izervay (avacincaptad pegol intravitreal solution) that revises the labeling for the drugs use in...